Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization
New integrated workflow combines icIEF fractionation and mass photometry Enables direct characterization of aggregation and size within icIEF-resolved charge variants Four-hour workflow reduces development risk and accelerates biosimilar manufacturing MINNEAPOLIS and OXFORD, England, June...
View original →